Autoimmune disorders and quadrivalent human papillomavirus vaccination of young female subjects

Affiliation auteurs!!!! Error affiliation !!!!
TitreAutoimmune disorders and quadrivalent human papillomavirus vaccination of young female subjects
Type de publicationJournal Article
Year of Publication2014
AuteursGrimaldi-Bensouda L., Guillemot D., Godeau B., Benichou J., Lebrun-Frenay C., Papeix C., Labauge P., Berquin P., Penfornis A., Benhamou P.-Y, Nicolino M., Simon A., Viallard J.-F, Costedoat-Chalumeau N., Courcoux M.-F, Pondarre C., Hilliquin P., Chatelus E., Foltz V., Guillaume S., Rossignol M., Abenhaim L., Grp PGR-AIDStudy
JournalJOURNAL OF INTERNAL MEDICINE
Volume275
Pagination398-408
Date PublishedAPR
Type of ArticleArticle
ISSN0954-6820
Mots-clésautoimmune disorders, Human papillomavirus, human papillomavirus vaccine, systematic case-control study, vaccination, vaccine safety
Résumé

Objectives The aim of this study was to investigate whether the quadrivalent human papillomavirus (HPV) vaccine Gardasil is associated with a change in the risk of autoimmune disorders (ADs) in young female subjects. Design Systematic case-control study of incident ADs associated with quadrivalent HPV vaccination in young women across France. Participants and setting A total of 113 specialised centres recruited (from December 2007 to April 2011) females aged 14-26years with incident cases of six types of ADs: idiopathic thrombocytopenic purpura (ITP), central demyelination/multiple sclerosis (MS), Guillain-Barre syndrome, connective tissue disorders (systemic lupus erythematosus, rheumatoid arthritis/juvenile arthritis), type 1 diabetes mellitus and autoimmune thyroiditis. Control subjects matched to cases were recruited from general practice. Analysis Multivariate conditional logistic regression analysis; factors included age, geographical origin, smoking, alcohol consumption, use of oral contraceptive(s) or vaccine(s) other than Gardasil received within 24months before the index date and personal/family history of ADs. Results Overall, 211 definite cases of ADs were matched to 875 controls. The adjusted odds ratio (OR) for any quadrivalent HPV vaccine use was 0.9 [95% confidence interval (CI) 0.5-1.5]. The individual ORs were 1.0 (95% CI 0.4-2.6) for ITP, 0.3 (95% CI 0.1-0.9) for MS, 0.8 (95% CI 0.3-2.4) for connective disorders and 1.2 (95% CI 0.4-3.6) for type 1 diabetes. No exposure to HPV vaccine was observed in cases with either Guillain-Barre syndrome or thyroiditis. Conclusions No evidence of an increase in the risk of the studied ADs was observable following vaccination with Gardasil within the time periods studied. There was insufficient statistical power to allow conclusions to be drawn regarding individual ADs.

DOI10.1111/joim.12155